Favorable Cardiac Risk among Elderly Breast Carcinoma Survivors [1] (multiple letters)

Cancer

Volumn 100, Issue 4, 2004, Pages 878-879

  Conti, Elena ^a   Marchese, Nicola ^a   Andreotti, Felicita ^a   Lamont, Elizabeth B ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SOMATOMEDIN C; TAMOXIFEN;

AGING; ANGIOGENESIS; APOPTOSIS; BREAST CARCINOMA; CANCER SURVIVAL; CARDIOVASCULAR RISK; CLINICAL TRIAL; FOLLOW UP; HEART INFARCTION; HEART PROTECTION; HUMAN; LETTER; LONG TERM EXPOSURE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, HORMONAL; BIOLOGICAL AVAILABILITY; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MYOCARDIAL INFARCTION; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TAMOXIFEN;

EID: 0842347568     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20041     Document Type: Letter

References (0)